Anti-FKRP/ LGMD2I/ LGMDR9 functional antibody

Anti-FKRP/ LGMD2I/ LGMDR9 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FKRP/FKRP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0222-Ab-1/ GM-Tg-hg-SE0222-Ab-2Anti-Human FKRP monoclonal antibodyHuman
GM-Tg-rg-SE0222-Ab-1/ GM-Tg-rg-SE0222-Ab-2Anti-Rat FKRP monoclonal antibodyRat
GM-Tg-mg-SE0222-Ab-1/ GM-Tg-mg-SE0222-Ab-2Anti-Mouse FKRP monoclonal antibodyMouse
GM-Tg-cynog-SE0222-Ab-1/ GM-Tg-cynog-SE0222-Ab-2Anti-Cynomolgus/ Rhesus macaque FKRP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0222-Ab-1/ GM-Tg-felg-SE0222-Ab-2Anti-Feline FKRP monoclonal antibodyFeline
GM-Tg-cang-SE0222-Ab-1/ GM-Tg-cang-SE0222-Ab-2Anti-Canine FKRP monoclonal antibodyCanine
GM-Tg-bovg-SE0222-Ab-1/ GM-Tg-bovg-SE0222-Ab-2Anti-Bovine FKRP monoclonal antibodyBovine
GM-Tg-equg-SE0222-Ab-1/ GM-Tg-equg-SE0222-Ab-2Anti-Equine FKRP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0222-Ab-1/ GM-Tg-hg-SE0222-Ab-2; GM-Tg-rg-SE0222-Ab-1/ GM-Tg-rg-SE0222-Ab-2;
GM-Tg-mg-SE0222-Ab-1/ GM-Tg-mg-SE0222-Ab-2; GM-Tg-cynog-SE0222-Ab-1/ GM-Tg-cynog-SE0222-Ab-2;
GM-Tg-felg-SE0222-Ab-1/ GM-Tg-felg-SE0222-Ab-2; GM-Tg-cang-SE0222-Ab-1/ GM-Tg-cang-SE0222-Ab-2;
GM-Tg-bovg-SE0222-Ab-1/ GM-Tg-bovg-SE0222-Ab-2; GM-Tg-equg-SE0222-Ab-1/ GM-Tg-equg-SE0222-Ab-2
Products NameAnti-FKRP monoclonal antibody
Formatmab
Target NameFKRP
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FKRP benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0222-Ag-1Recombinant multi-species FKRP/ LGMD2I/ LGMDR9 protein
    ORF Viral VectorpGMLP001501human FKRP Lentivirus plasmid
    ORF Viral VectorvGMLP001501human FKRP Lentivirus particle
    ORF Viral VectorpGMLPm003844mouse Fkrp Lentivirus plasmid
    ORF Viral VectorvGMLPm003844mouse Fkrp Lentivirus particle


    Target information

    Target IDGM-SE0222
    Target NameFKRP
    Gene ID79147,243853,308390,716804,484426,101099604,539701,102148152
    Gene Symbol and SynonymsA830029B19Rik,FKRP,FKTR,LGMD1I,LGMD2I,LGMDR9,MDC1C,MDDGA5,MDDGB5,MDDGC5
    Uniprot AccessionQ9H9S5
    Uniprot Entry NameFKRP_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000181027
    Target ClassificationN/A

    The target: FKRP, gene name: FKRP, also named as LGMD2I, LGMDR9, MDC1C, MDDGA5, MDDGB5, MDDGC5. This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.